India’s first mRNA vaccine under final trials: Dr V.K. Paul

India’s first homegrown Messenger RNA (mRNA) Covid19 vaccine, being developed by Pune-based Gennova Biopharmaceuticals, is currently under final clinical trials, NITI Aayog’s Member, Health, Dr. V.K. Paul, said on Thursday. Briefing the media, he said that they are hopeful that they will be able to use this vaccine soon.